hypophosphatemia%20-and-%20hyperphosphatemia
HYPOPHOSPHATEMIA & HYPERPHOSPHATEMIA

Hypophosphatemia is an electrolyte imbalance where there is a decrease in the serum phosphate level that is less than the normal range.

It is recognized most often in critically-ill patients, decompensated diabetics, alcoholics or other malnourished persons, and acute infectious or pulmonary disorders.

It may be transient and reflect intracellular shift with minimal clinical consequences.

Hyperphosphatemia is an electrolyte disturbance in which an increase in the serum phosphate level of more than the normal range is present.

Most symptoms of acute hyperphosphatemia are due to secondary hypocalcemia.

The significant level of hyperphosphatemia in adults is >6 mg/dL.

Introduction

Hypophosphatemia is recognized most often in:
  • Critically-ill patients
  • Decompensated diabetics
  • Alcoholics or other malnourished persons
  • Acute infectious or pulmonary disorders
  • Patients who are in IV hyperalimentation without phosphate supplementation
  • Patients w/ urinary phosphate-wasting syndromes (eg Fanconi syndrome or tumor-induced osteomalacia)

Hyperphosphatemia

  • Defined as an electrolyte disturbance in which an increase in the serum phosphate level of more than the normal range is present

Etiology

Hypophosphatemia 

  • More pronounced when there is underlying phosphate depletion (eg hyperparathyroidism,vitamin D deficiency, alcoholism & glycosuria)
  • Mechanisms that may cause hypophosphatemia:
    • Increased urinary losses due to impaired intestinal absorption
    • Redistribution of phosphate from extracellular fluid into the intracellular space or the mineral phase of bone
    • Severe & selective deprivation of dietary phosphate that rarely occurs

Hyperphosphatemia

  • Decreased Renal Phosphate Excretion
    • Renal failure
    • Hypoparathyroidism
    • Pseudohypoparathyroidism
    • Familial tumoral calcinosis
    • Bisphosphonate therapy
    • Vitamin D intoxication
    • Acromegaly
    • Mg deficiency
  • Others
    • Acid-base disorders
    • Crush injuries
    • Fulminant hepatitis
    • Rhabdomyolysis
    • Artifactual due to hemolysis
    • Extracellular shift from intracellular compartment
    • Chronic Heparin therapy

Signs and Symptoms

Hypophosphatemia
Mild
  • Usually asymptomatic
Moderate-Severe
  • Confusion
  • Irritability
  • Apprehension
  • Fatigue
  • Myalgia & myopathy
  • Muscle weakness
  • Numbness
  • Paresthesia
  • Rhabdomyolysis
  • Seizures
  • Coma
  • Reversible respiratory failure
  • Impairment of cardiac contractility
  • Cardiomyopathy
  • Hemolysis
  • Thrombocytopenia
  • Impaired phagocytosis
  • Metabolic encephalopathy
  • Rickets & osteomalacia
Hyperphosphatemia
Acute - 
Most symptoms are due to secondary hypocalcemia
  • Hypocalcemia
  • Neuromuscular irritability/muscle cramps
  • Tetany
  • Paresthesias
  • Seizures
  • Hypotension
  • Cardiac arrhythmia

Chronic - Persistent hyperphosphatemia (>12 hours) that usually occurs in patients w/ chronic renal failure & familial tumoral calcinosis

  • Normocalcemia
  • Nephrocalcinosis
  • Soft tissue or vascular calcification
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 20 Jul 2018
Women with pre-eclampsia or gestational hypertension during their first pregnancy had an increased risk of developing chronic hypertension, type 2 diabetes (T2D), and hypercholesterolaemia than those who were normotensive during pregnancy, according to a study. The risk persisted for several decades later, signalling these hypertensive disorders of pregnancy (HDP) as red flags for cardiovascular (CV) health for life.
Roshini Claire Anthony, 30 Jul 2018

Canagliflozin may provide a renoprotective effect in individuals with type 2 diabetes (T2D) and a history of cardiovascular disease (CVD), according to results from the CANVAS* Program.

Stephen Padilla, 31 Jul 2018
Patients with type 2 diabetes (T2D) treated with sulphonylureas as second-line drugs are at an increased risk of myocardial infarction (MI), all-cause mortality and severe hypoglycaemia compared with those who remained on metformin monotherapy, a recent study has found.
22 Jul 2018
There appears to be a nonlinear relationship between total oestradiol and free oestradiol and all-cause mortality among older men, according to data from the Three-City cohort study. Specifically, the association is stronger for cardiovascular disease mortality and nonexistent for cancer mortality.